Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Nature Medicine explores the latest translational and clinical research news, with positive efficacy and safety data from Sanofi’s treatment for autoimmune disease.
A smartphone-based intervention package for community health workers led to an improvement in the treatment of common childhood illnesses when delivered at scale in Mozambique.
Pandemic preparedness plans must include equitable access to diagnostics, vaccines and therapeutics, as well as strategies to build trust and combat disinformation.
Women who are pregnant, lactating or of childbearing potential are commonly excluded from cardiovascular randomized controlled trials — this needs to change.
Endometriosis has long been understudied; now, research suggests that Fusobacterium infection may cause the condition — and that antibiotics could be used to treat it.
Nature Medicine explores the latest translational and clinical research news, with results from a small expansion cohort of the phase 2b SYMMETRY trial in patients with type 2 diabetes and non-alcoholic steatohepatitis.
Enhanced informed consent procedures are needed for patients treated with psychedelics such as psilocybin and MDMA, due to effects that include an altered state of consciousness and vulnerability to suggestion.
The dual IDH1–IDH2 inhibitor vorasidenib more than doubled time to progression (relative to placebo) and thus represents the first new treatment in decades for patients with glioma.